Skip to main content
OpenTrials
Completed

NCT Number: NCT04785417

Effect of Touch Screen Tablet on Fine Motor Functions

the objective of this study to asses the effect of touch screen tablet on fine motor functions

Completed

Looking for future studies?

Notify Me

Key information

Age range

4 year–6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hanaa Mohsen

Cairo, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • hemiplegia
  • mid spasticity of upper limb
  • able to follow instructions

Exclusion criteria

  • fixed deformities visual or respiratory problem

Treatment and study plan

touch screen tablet

Other

traditional occupational therapy in addition to games on tablet

Primary outcomes

  1. pinch gauge

    Time frame: pre and post three month of intervention increase score indicate improvement

    used to asses pinch strength

  2. QUEST

    Time frame: pre and post three month of intervention increase score indicate improvement

    to asses the fine motor function

  3. nine hole pegboard test

    Time frame: pre and post three month of intervention increase score indicate improvement

    used to asses the fine motor function

Sponsors and collaborators

Lead sponsor

Badr University

Other

Registry information

Official study title

Effect of Touch Screen Tablet on Fine Motor Function un Children With Hemiparetic Cerebral

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Mar 5, 2021
Registry last updated
May 10, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.